Effects of short-term reduction in serum cholesterol with Simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia

American Journal of Cardiology

Volumn 78, Issue 7, 1996, Pages 763-768

  De Divitiis, Marcello ^a   Rubba, Paolo ^b   Di Somma, Salvatore ^b   Liguori, Vincenzo ^b   Galderisi, Maurizio ^b   Montefusco, Silvana ^b   Carreras, Giovanni ^b   Greco, Vincenzo ^b   Carotenuto, Andrea ^b   Iannuzzo, Gabriella ^b   De Divitiis, Oreste ^b  

^a NONE   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DRUG DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; SIMVASTATIN;

ANALYSIS OF VARIANCE; ANGINA PECTORIS; ARTICLE; BLOOD; BLOOD FLOW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; EXERCISE TEST; FOREARM; HUMAN; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANGINA PECTORIS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; ELECTROCARDIOGRAPHY; EXERCISE TEST; FOREARM; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MIDDLE AGED; REGIONAL BLOOD FLOW; SIMVASTATIN; SINGLE-BLIND METHOD;

EID: 10644246118     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00417-1     Document Type: Article

References (26)

1. Harrison DG. Endothelial dysfunction in coronary microcirculation: clinical entity or an experimental finding? J Clin Invest 1993;91:1-2.
2. Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependent vascular relaxation is abnormal in the coronary microcirculation of atherosclerotic primates. Circulation 1990;81:1586-1593.
3. Andrews HE, Bruckdorfer KR, Dunn RC. Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 1987;327:237-239.
4. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228-234.
5. Vita JA, Treasure CB,Nabel EJ, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors coronary artery disease. Circulation 1990;81:491-497.
6. Zeiher AM, Drexler H, Saurbier B, Just H. Effects of age, atherosclerosis, hypercholesterolemia and hypertension: endothelium-mediated coronary blood flow modulation in humans. J Clin Invest 1993;92:652-662.
7. Egashira K, Inou T, Yamada A, Hirooka Y, Maruoka Y, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and coronary atherosclerotic lesions. J Clin Invest 1993;91:29-37.
8. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808-1811.
9. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995;332:512-515.
10. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, Zhang J, Boccuzzi SJ, Cedarholm JC, Alexander RW. Beneficial effect of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995;332:481-487.
11. Anderson TJ, Meredith IT, Yeung AG, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995;332:488-493.
12. Egashira K, Yoshitaka H, Hisashi K, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with Pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994;89:2519-2524.
13. Lance-Gould K, Martucci JP, Goldberg DI, Hess MJ, Edens RP, Latifi R, Dudrick SJ. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dypiridamole in patients with coronary artery disease. Circulation 1994; 89:1530-1538.
14. Eichstaedt HW, Eskoetter H, Hoffmann I, Amthauer HW, Weidinger G. Improvement of myocardial perfusion by short-term Fluvastatin therapy in coronary artery disease. Am J Cardiol 1995;76:122A-125A.
15. Schmieder RE, Schobel HP. Is endothelial dysfunction reversible? Am J Cardiol 1995;76:117A-121A.
16. Rubba P, Iannuzzi A, Postiglione A, Scarpato N, Montefusco S, Gnasso A, Nappi G, Cortese C, Mancini M. Haemodynamic changes in the peripheral circulation after repeat low density lipoprotein apheresis in familial hypercholesterolemia. Circulation 1990;81:610-616.
17. Rubba P, Faccenda F, Di Somma S, Gnasso A, Scarpato N, Iannuzzi A, Nappi G, Postiglione A, de Divitiis O, Mancini M. Cerebral blood flow velocity and systemic vascular resistance after acute reduction of low density lipoprotein in familial hypercholesterolemia. Stroke 1993;24:1154-1161.
18. De Divitiis O, De Simone G, Maddalena G, Castaldo M, Ruggiano A. Gli effetti di una dose singola orale di Atenololo valutati con test da sforzo in pazienti con angina pectoris stabile. G Ital Cardiol 1981;11:2088-2096.
19. De Divitiis O, Liguori V, Di Somma S, Brignoli M, Ferraro S, Petitto M, Fazio S, Marsullo G, Salvatore M, Gradnik R. Bisoprolol in the treatment of angina pectoris: a double-blind comparison with Verapamil. Eur Heart J 1987;8(suppl M) 43-54.
20. Pepine CJ. New insights in the measurement of myocardial ischaemia. Am J Cardiol 1992;70:19g-25g.
21. Malini PL, Ambrosioni E, de Divitiis O, Di Somma S, Rosiello G, Trimarco B. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia. Clin Ther 1991;13:500-510.
22. The European Study Group. Efficacy and tolerability of simvastatin and pravastatin in patients with primary hypercholesterolemia (multicountry comparative study). Am J Cardiol 1993;70:1281-1286.
23. Koenig W, Ernst E. The possible role of hemorheology in atherothrombogenesis. Atherosclerosis 1992;94:93-107.
24. Lowe GDO. Blood rheology in arterial disease. Clin Sci 1986;71:137-146.
25. Furchgott RF. Role of endothelium in responses of vascular smooth muscle. Circ Res 1983;53:557-573.
26. Gilligan DM, Panza JA, Kilcayne CM. Contribution of endothelium-derived nitric oxide to exercise induced vasodilation. Circulation 1994;90: 2853-2858.